The Anatomy of Neglect: Reassessing the Forgotten Clinical Reality of Visceroptosis on August 22, 2026 Posted by
The Silent Synergy: How Abdominal Obesity and Vitamin D Deficiency Drive Mortality in Aging Populations on August 22, 2026 Posted by
Architect of Resilience: Dr. Angela Neal-Barnett and the New Frontier of Black Mental Health on August 22, 2026 Posted by
The High Cost of a Quick Fix: Why Energy Drinks Pose a Significant Risk to Bipolar Stability on August 22, 2026 Posted by
Wake Up Refreshed: The Science-Backed Morning Routine to Eliminate Stiffness After 60 on August 22, 2026 Posted by
Bridging the Stroke Care Gap: ARPA-H Invests $175M in Autonomous Surgical Robotics on August 22, 2026 Posted by
The Anatomy of Neglect: Reassessing the Forgotten Clinical Reality of Visceroptosis on August 22, 2026 Posted by
The Silent Synergy: How Abdominal Obesity and Vitamin D Deficiency Drive Mortality in Aging Populations on August 22, 2026 Posted by
Architect of Resilience: Dr. Angela Neal-Barnett and the New Frontier of Black Mental Health on August 22, 2026 Posted by
Posted in Medical Innovations A New Dawn for GSDIa: FDA Approves First Gene Therapy for Von Gierke Disease on August 21, 2026
Posted in Digital Health Tools From Cornstarch to Gene Therapy: The Landmark FDA Approval for GSDIa on August 20, 2026
Posted in Medical Innovations Advancements in Medicine: From Gene-Editing Breakthroughs to Dementia Prevention on August 15, 2026
Posted in Digital Health Tools PTC Therapeutics Secures Fabry Disease Gene Therapy in Landmark $211 Million Bankruptcy Auction on August 14, 2026
Posted in Medical Innovations High-Stakes Bet: PTC Therapeutics Secures Sangamo’s Gene Therapy Asset in Bankruptcy Auction on August 14, 2026
Posted in Medical Innovations Scribe Therapeutics Breaks Gene Editing IPO Drought with $129 Million Offering on July 24, 2026
Posted in Medical Innovations Biotech Weekly Roundup: From ARPA-H Gene Therapy Blueprints to Strategic Market Realignment on July 11, 2026
Posted in Medical Innovations MeiraGTx Secures $400 Million Lifeline from Oberland Capital to Accelerate Gene Therapy Portfolio on July 7, 2026
Posted in Respiratory Health FDA Expands Landmark CRISPR Gene Therapy Access to Toddlers with Sickle Cell and Beta Thalassemia on July 2, 2026
Posted in Medical Innovations From Gene Therapy High-Flyer to Strategic Exit: The Transformation of Passage Bio on June 25, 2026
